Home › Funds › RTW INVESTMENTS, LP › OBIO
RTW INVESTMENTS, LP position in OBIO
ORCHESTRA BIOMED HLDGS INC · Health Care
RTW INVESTMENTS, LP reported holding 9,556,063 shares of OBIO (ORCHESTRA BIOMED HLDGS INC) in its Q3 2026 13F filing — a position valued at US$59.4M, representing 0.60% of its reported portfolio and ranking #43 among its reported holdings. RTW INVESTMENTS, LP has disclosed OBIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's OBIO position evolved
RTW INVESTMENTS, LP first disclosed a stake in OBIO in Q3 2023 at 5,620,640 shares (US$49.0M). The position peaked in Q3 2026 at 9,556,063 shares, worth US$59.4M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 9,556,063 shares valued at US$59.4M. Notable position changes include a 46% increase in Q3 2024 (shares fell 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.62M | $49.01M | New |
| Q4 2023 | 5.62M | $51.32M | Hold |
| Q1 2024 | 5.62M | $29.62M | Hold |
| Q2 2024 | 5.62M | $45.81M | Hold |
| Q3 2024 | 8.21M | $42.18M | Add |
| Q4 2024 | 8.21M | $32.82M | Hold |
| Q1 2025 | 8.21M | $35.12M | Hold |
| Q2 2025 | 8.31M | $22.26M | Add |
| Q3 2025 | 8.31M | $20.60M | Hold |
| Q4 2025 | 8.31M | $34.47M | Hold |
| Q1 2026 | 8.31M | $35.30M | Hold |
| Q2 2026 | 9.56M | $41.23M | Add |
| Q3 2026 | 9.56M | $59.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OBIO and 13F data
OBIO (ORCHESTRA BIOMED HLDGS INC) is a Health Care company. 45 other funds we track also report a position in OBIO — the largest reported positions include Propel Bio Management, LLC (US$5.6M), Knott David M Jr (US$1.6M), Flat Footed LLC (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OBIO
- Propel Bio Management, LLC 896.70K sh · $5.58M · Q3 2026
- Knott David M Jr 253.65K sh · $1.58M · Q3 2026
- Flat Footed LLC 251.37K sh · $1.08M · Q2 2026
- Daytona Street Capital LLC 123.15K sh · $743.81K · Q3 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held OBIO?
RTW INVESTMENTS, LP has disclosed OBIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in OBIO?
As of Q3 2026, RTW INVESTMENTS, LP holds 9.56M shares of OBIO (ORCHESTRA BIOMED HLDGS INC), valued at $59.44M, representing 0.60% of its reported portfolio and ranking #43.
Has RTW INVESTMENTS, LP been buying or selling OBIO?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in OBIO. The position peaked in Q3 2026 at 9.56M shares.
Which other funds hold OBIO?
Other major institutional holders of OBIO include Propel Bio Management, LLC, Knott David M Jr, Flat Footed LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.